Position in QGEN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,713,870
+$1,445,763 QoQ
Shares Held
43,833
+554.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#142
of 336 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $44,798,846 across 16 Diagnostics & Research names. QGEN ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
53,557 | $9,303,386 | |
| 2 | ILMN |
Illumina, Inc.
|
51,349 | $9,028,694 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
15,145 | $8,020,640 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
8,920 | $4,695,844 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
7,931 | $3,976,286 | |
| 6 | NTRA |
Natera, Inc.
|
6,739 | $1,829,301 | |
| 7 | QGEN |
Qiagen N.V.
This page
|
43,833 | $1,713,870 | |
| 8 | A |
Agilent Technologies, Inc.
|
12,355 | $1,641,114 |
All Filings in QGEN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,713,870 | 43,833 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $268,107 | 6,696 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,477,577 | 55,094 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,196,575 | 26,781 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||